Immediate Impact
2 from Science/Nature 65 standout
Citing Papers
Borderline Personality Disorder
2023 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Works of Netta Horesh being referenced
A Comparison of Life Events in Adolescents with Major Depression, Borderline Personality Disorder and Matched Controls: A Pilot Study
2008
Life events and suicidality in adolescents with schizophrenia
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Netta Horesh | 1536 | 422 | 611 | 41 | 2.0k | |
| Anna Higgitt | 1823 | 328 | 900 | 39 | 2.5k | |
| Jason D. Jones | 966 | 208 | 609 | 48 | 1.7k | |
| Timothy R. Stickle | 1677 | 263 | 767 | 38 | 2.4k | |
| Alan E. Fruzzetti | 2018 | 496 | 705 | 59 | 2.5k | |
| Christine A. Padesky | 1250 | 231 | 666 | 33 | 1.9k | |
| Fergal W. Jones | 1675 | 241 | 514 | 71 | 2.4k | |
| Meyer D. Glantz | 1459 | 415 | 386 | 34 | 3.1k | |
| Mirjami Pelkonen | 1447 | 289 | 459 | 39 | 1.9k | |
| Kathleen Kara Fitzpatrick | 1596 | 434 | 622 | 36 | 2.7k | |
| M. B. Shapiro | 1052 | 362 | 627 | 46 | 2.4k |
All Works
Loading papers...